Skip to main content

Advertisement

An Early, Unreleased Study Suggested Avandia Couldn't Beat Actos

New allegations about GlaxoSmithKline's handling of safety questions about Avandia have surfaced. (Getty Images)
New allegations about GlaxoSmithKline's handling of safety questions about Avandia have surfaced. (Getty Images)

Advertisement

Advertisement

Listen Live